Executive Leadership

  • Simon Alexander Mallal, M.B.B.S

    CFAR Program Director and Administrative Core Director at Vanderbilt, Professor
    Medicine and Pathology, Microbiology, and Immunology Vanderbilt University School of Medicine

    Dr. Mallal has championed research that has driven improvements in clinical practice in HIV and infectious diseases since the early years of the AIDS epidemic.  He provides scientific vision and leadership, promoting collaborations on all types of HIV research within and across the institutions (especially translational and disparities-related research), improving communications and outreach to the community, and fostering productive interactions with colleagues at other academic institutions. He chairs the Executive Committee (EC) of the TN-CFAR.

  • James E.K. Hildreth, M.D., Ph.D.

    Associate CFAR Director at Meharry
    President and CEO of Meharry Medical College

    Dr. Hildreth serves as the Associate CFAR Director at Meharry.  He promotes expansion of all types of HIV research at Meharry.  He emphasizes and promotes improved visibility of HIV biological and clinical research, and research training at Meharry. He provides scientific vision and leadership, promoting collaborations on all types of HIV research within and across the institutions, improving communications and outreach to the community, and fostering productive interactions with colleagues at other academic institutions. 

  • David W Haas, M.D.

    Associate CFAR Director at Vanderbilt
    Professor of Medicine, Pharmacology, Pathology, Microbiology & Immunology, Vanderbilt University School of Medicine; Adjunct Professor of Internal Medicine, Meharry Medical College

    Dr. Haas provides clinical expertise, a strong NIH-funded clinical trials background, and a long history at Vanderbilt. He serves as Associate CFAR Director at Vanderbilt, as well as the Director of the Clinical Sciences Core. He is directly involved in the administration of the Tennessee CFAR at Vanderbilt, as well as in the Nashville HIV/AIDS provider community. He has developed many important collaborations, particularly in areas of genomics and pharmacology. His enthusiasm and energy has already drawn many new investigators into HIV research. He has aso established connections between our campuses. He continues to foster interactions with colleagues at other academic institutions. He is directly involved in all Executive Committee and Advisory Board activities and helps monitor Scientific Working Group progress and oversees all Clinical Sciences Core activities.

  • Bryan Shepherd, PhD

    Professor and Vice Chair of Research
    Biostatistics Department, Vanderbilt University School of Medicine

    Dr. Shepherd directs the Biostatistics and Biomedical Informatics Core of the TN-CFAR.  Dr. Shepherd has been involved in many studies of HIV/AIDS since 2000, including observational studies, laboratory studies, and randomized clinical trials.  Dr. Shepherd has also developed novel statistical methods of relevance to studies of HIV/AIDS, with a focus on methods for causal inference, ordinal data analysis, and addressing measurement error.